Phase 3 Trial of Experimental Progressive Familial Intrahepatic Cholestasis Drug for Pediatric Patients Begins
<a href="https://pixabay.com/users/DarkoStojanovic/">DarkoStojanovic</a> / Pixabay

Phase 3 Trial of Experimental Progressive Familial Intrahepatic Cholestasis Drug for Pediatric Patients Begins

According to a story from drugs.com, the biopharmaceutical company Mirum Pharmaceuticals recently announced that they have begun dosing the first patient in a phase 3 clinical trial. This clinical trial…

Continue Reading
A Potential Drug for Progressive Familial Intrahepatic Cholestasis Achieves Fast Track Designation
<a href="https://pixabay.com/users/jniittymaa0/">jniittymaa0</a> / Pixabay

A Potential Drug for Progressive Familial Intrahepatic Cholestasis Achieves Fast Track Designation

The United States Food and Drug Administration has granted Fast Track designation to a drug being researched as a potential treatment for progressive familial intrahepatic cholestasis, a serious liver disease…

Continue Reading
Close Menu